Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2015 / Cilt: 24 - Sayı: 1

Hemodiyaliz hastalarında hemoglobin stabilitesi, eritropoetin ihtiyacıve vücut kompozisyon analizi ilişkisi

The Relationship between body composition analysis, erythropoietin requirements and hemoglobin variability in hemodialysis patients

Pages
17–22
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients were grouped according to Hb variability during last 6 months as GroupLS (low stable, Hb

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJEctIVE: Despite of similar body weight and body mass index patients might have different bodycomposition.
📊
Key Findings & Data:Our aim was to analyze the relationship between Hb variability, rHuEPO requirementsand body composition analysis of MHD patients.MAtErIAL and MEtHOdS: Monthly laboratory values and rHuEPO requirements of 110 MHDpatients were collected.
💡
Conclusion & Impact:Patients were grouped according to Hb variability during last 6 months as GroupLS (low stable, Hb
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJEctIVE: Despite of similar body weight and body mass index patients might have different bodycomposition. Our aim was to analyze the relationship between Hb variability, rHuEPO requirementsand body composition analysis of MHD patients.MAtErIAL and MEtHOdS: Monthly laboratory values and rHuEPO requirements of 110 MHDpatients were collected. Patients were grouped according to Hb variability during last 6 months as GroupLS (low stable, Hb

Özet

AMAÇ: Benzervücutağırlığıvevücutkitleindeksinesahipolmalarınarağmenhemodiyalizhastalaryağvekaskitlesigibifarklıvücutkomponentiyüzdelerinesahipolabilirler.Bizbuçalışmadahemodiyalizhastalarındahemoglobindeğişkenliği,eritropoetinihtiyacı(rHuEPO)vevücutkompozisyonanalizarasındakiilişkiyisaptamayıamaçladık.GErEÇ ve yÖNtEMLEr: 110hemodiyalizhastasınınaylıklaboratuvardeğerleriverHuEPOihtiyaçlarıkaydedildi.Hastalarson6aylıkHbdeğişkenliklerinegöre3grubaayrıldı;GrupLS(düşükstabil,Hb

🔖

Cite This Article

SEZER, S., TUTAL, E., HABERAL, M., BOZKURT, T., BAL, Z., UYAR, M. E., ÖZDEMİR, N. A. (2022). Hemodiyaliz hastalarında hemoglobin stabilitesi, eritropoetin ihtiyacıve vücut kompozisyon analizi ilişkisi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 24 - Sayı: 1, 17–22. https://ajindex.com/articles/654999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 1999;14 Suppl 5:1-50
  2. Macdougall IC; Steering Committee of the CREATE trial; CREATE Study Group: CREATE: new strategies for early anaemia management in renal insuffciency. Nephrol Dial Transplant 2003;18 Suppl 2:ii13-16 3. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355(20):2085- 2098 4. Collins AJ: Anaemia management prior to dialysis: Cardiovascular and cost-beneft observations. Nephrol Dial Transplant 2003;18 Suppl 2:ii2-6 5. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI: Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 2007;18:3164-3170 6. Kovesdy CP, Kalantar-Zadeh K: Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 2009;9:3-14 7. National Kidney Foundation: K/DOQI. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35:1- 140 8. Pupim LB, Kent P, Ikizler TA: Bioelectrical impedance analysis in dialysis patients. Miner Electrolyte Metab 1999;25:400-406 9. Ebben JP, Gilbertson DT, Foley RN, Collins AJ. Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 2006;1(6):1205-1210 10. Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Ureña P, Iñigo P, Minutolo R, Haviv YS, Yeates K, Agüera ML, MacRae JM, Levin A: Hemoglobin variability in nondialysis chronic kidney disease: Examining the association with mortality. Clin J Am Soc Nephrol 2009;4(7):1176-1182 11. Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ: Hemoglobin level variability: Anemia management among variability groups. Am J Nephrol 2009;30(6):491-498 12. Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997;29:565-568 13. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD: Effect of malnutrition-infammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003;42:761-773 14. Dellanna F, Hetze